OXSTEM
OxStem plans to develop small molecule drugs that can activate repair mechanisms that already exist within the body. Building on decades of experience in medicinal chemistry, OxStem will design drugs that can programme resident stem and stem-like cells in situ to treat currently untreatable age-related conditions.
OXSTEM
Industry:
Biotechnology Health Care Life Science
Founded:
2013-01-01
Address:
Oxford, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.oxstem.co.uk
Total Employee:
1+
Status:
Closed
Contact:
+44 0 20 7630 2180
Email Addresses:
[email protected]
Total Funding:
24.42 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Namesco DNS
Current Employees Featured
Founder
Investors List
Human Longevity
Human Longevity investment in Venture Round - OxStem
Oxford Science Enterprises
Oxford Science Enterprises investment in Seed Round - OxStem
Official Site Inspections
http://www.oxstem.co.uk
- Host name: 44.76.156.118
- IP address: 44.76.156.118
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "OxStem"
OxSTEM - Home
OxSTEM is a 501(c)(3) nonprofit, all-volunteer charity focused on STEM (science, technology, engineering, and mathematics)-related educational initiatives to benefit the lives of others. Our mission is to provide STEM-related donations, …See details»
OxStem Company Profile 2024: Valuation, Funding & Investors
OxStem General Information Description. Operator of a drug discovery company intended to develop cell programming and small molecule therapies that target innate regeneration and …See details»
OxStem - VentureRadar
We are a pioneering, clinical-stage T cell receptor biotechnology company working to develop and commercialize a new generation of transformative medicines to address unmet needs in …See details»
Oxstem Company Profile | Management and Employees List
OxStem discovers small molecules that activate or re-programme tissue-resident (endogenous) stem and progenitor cells, targeting diseases with significant unmet clinical needs. OxStem's …See details»
Record £16.9m for Oxford spinout designing stem cell drugs to …
May 10, 2016 OxStem has raised a record £16.9m, and established strategic partnerships with world class biotechnology companies and individual investors in this rapidly emerging scientific …See details»
OxStem - VentureRadar
OxStem discovers small molecules that activate or re-programm etissue-resident (endogenous) stem and progenitor cells, targeting diseases with significant unmet clinical needs. OxStem’s …See details»
OxStem - Funding, Financials, Valuation & Investors - Crunchbase
OxStem is a drug discovery company. How much funding has this organization raised over time? ShowSee details»
Record £16.9m for Oxford spinout Oxstem - University of Oxford
May 10, 2016 OxStem, an Oxford spin-out founded by Prof. Steve Davies, Prof. Angela Russell and DPAG's Prof. Dame Kay Davies, has raised a record £16.9M to develop small molecule …See details»
OxStem Company Profile - Office Locations, Competitors, Revenue …
OxStem is a regenerative medicine drug discovery company. It develops small molecule therapeutics targeting innate regeneration and repair. The company focuses on disorders such …See details»
OxStem - Oxford University Innovation
Contact Us. Oxford University Innovation Buxton Court 3 West Way Oxford OX2 0JB. T: +44 (0) 1865 280830 . E: [email protected]See details»
OxStem CEO and Key Executive Team | Craft.co
OxStem's Chairman and CEO is Stuart Collinson. Other executives include Kay Davies, Founder; Steve Davies, Founder and 11 others. See the full leadership team at Craft.See details»
Oxford spinout OxStem launches firms to tackle diabetes and …
OxStem Ltd, an Oxford University spinout developing regenerative medicine-based therapies, is launching two subsidiary companies to develop regenerative treatments for diabetes and …See details»
Oxford regenerative medicine spinout brings on GlaxoSmithKline …
Sep 10, 2018 OxStem itself acts as a parent holding company, overseeing and funding development of small molecule drugs at a series of subsidiaries, each focused on different …See details»
OxStem - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. OxStem . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 4. About. OxStem is …See details»
Regenerative medicine spinout OxStem launches subsidiaries
Oct 5, 2018 Subsidiaries of the Oxford University spinout, OxStem Immuno and OxStem Beta, will draw on research from the institution. OxStem Ltd, an Oxford University spinout …See details»
UK regenerative medicine biotech appoints veteran 'drug hunter' …
Sep 10, 2018 The UK regenerative medicine biotech OxStem has appointed former GSK and AbbVie executive Georg Terstappen as chief scientific officer. OxStem hopes to develop small …See details»
OxStem - Contacts, Employees, Board Members, Advisors
Organization. OxStem . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. About. OxStem has 3 …See details»
Oxford University spinoff OxStem gains record funding, big names
May 11, 2016 OxStem has closed a £16.9 million ($24.4 million) fundraising round to design stem cell drugs that treat age-related diseases, with Dr. J. Craig Venter, Bob Duggan and Dr.See details»
Des Moines-based organization selected to lead state's new …
3 days ago An Iowa-based health care association has been selected by the state to manage Iowa's new behavioral health system. Gov. Kim Reynolds signed into law earlier this year a …See details»